Debt-to-equity of IOVANCE BIOTHERAPEUTICS, INC. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IOVANCE BIOTHERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 28%, a 1.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 28% 0% -1.1% 30 Sep 2025
Q2 2025 28% 0% -0.28% 30 Jun 2025
Q1 2025 27% -3% -8.8% 31 Mar 2025
Q4 2024 27% -1% -3.5% 31 Dec 2024
Q3 2024 28% 0% +1.4% 30 Sep 2024
Q2 2024 28% -2% -8.1% 30 Jun 2024
Q1 2024 30% -1% -2.1% 31 Mar 2024
Q4 2023 28% -3% -9.9% 31 Dec 2023
Q3 2023 28% -1% -3.8% 30 Sep 2023
Q2 2023 31% +6% +25% 30 Jun 2023
Q1 2023 30% +9% +45% 31 Mar 2023
Q4 2022 31% +13% +72% 31 Dec 2022
Q3 2022 29% +13% +77% 30 Sep 2022
Q2 2022 24% +10% +71% 30 Jun 2022
Q1 2022 21% +8% +67% 31 Mar 2022
Q4 2021 18% +6% +52% 31 Dec 2021
Q3 2021 17% +6% +51% 30 Sep 2021
Q2 2021 14% +3% +24% 30 Jun 2021
Q1 2021 12% -1% -5.3% 31 Mar 2021
Q4 2020 12% +2% +19% 31 Dec 2020
Q3 2020 11% +4% +50% 30 Sep 2020
Q2 2020 12% 30 Jun 2020
Q1 2020 13% 31 Mar 2020
Q4 2019 10% 31 Dec 2019
Q3 2019 7% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.